Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis

被引:71
作者
Herbert, D
Paramasivan, CN
Venkatesan, P
Kubendiran, G
Prabhakar, R
Mitchison, DA
机构
[1] ST GEORGE HOSP,SCH MED,DEPT MED MICROBIOL,LONDON SW17 0RE,ENGLAND
[2] INDIAN COUNCIL MED RES,TB RES CTR,MADRAS 600031,TAMIL NADU,INDIA
关键词
D O I
10.1128/AAC.40.10.2296
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The bactericidal actions of ofloxacin and sulbactam-ampicillin, alone and in combination with rifampin and isoniazid, on exponential-phase and stationary-phase cultures of a drug-susceptible isolate of Mycobacterium tuberculosis were studied in vitro, In exponential-phase cultures, all drugs were bactericidal, with the higher concentrations of ofloxacin (5 mu g/ml) and sulbactam-ampicillin (15 mu g of ampicillin per mi) being as bactericidal as 1 mu g of isoniazid per mi or 1 mu g of rifampin per mi, In two-drug combinations, both drugs increased the levels of activity of isoniazid and rifampin and were almost as bactericidal as isoniazid-rifampin; they also appeared to increase the level of activity of isoniazid-rifampin in three-drug combinations, In contrast, ofloxacin and sulbactam-ampicillin had little bactericidal activity against stationary-phase cultures and were less active than isoniazid or rifampin alone, Furthermore, in two-drug or three-drug combinations, they did not increase the level of activity of isoniazid, rifampin, or isoniazid-rifampin. These findings suggest that ofloxacin and sulbactam-ampicillin are likely to be most useful in the early stages of treatment and in preventing the emergence of resistance to other drugs but are unlikely to be effective as sterilizing drugs helping to kill persisting lesional bacilli.
引用
收藏
页码:2296 / 2299
页数:4
相关论文
共 21 条
  • [1] BUSH K, 1988, Clinical Microbiology Reviews, V1, P109
  • [2] A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis
    DeMaio, J
    Zhang, Y
    Ko, C
    Young, DB
    Bishai, WR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 2790 - 2794
  • [3] DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367
  • [4] INVITRO ACTIVITIES AGAINST MYCOBACTERIA OF 2 LONG-ACTING RIFAMYCINS, FCE22807 AND CGP40/469A (SPA-S-565)
    DICKINSON, JM
    MITCHISON, DA
    [J]. TUBERCLE, 1990, 71 (02): : 109 - 115
  • [5] FOULDS G, 1986, REV INFECT DIS, V8, pS503
  • [6] BACTERIOSTATIC AND BACTERICIDAL ACTIVITY OF CIPROFLOXACIN AND OFLOXACIN AGAINST MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-AVIUM COMPLEX
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    [J]. TUBERCLE, 1987, 68 (04): : 267 - 276
  • [7] HOBBY GL, 1957, AM REV TUBERC PULM, V6, P1031
  • [8] JINDANI A, 1980, AM REV RESPIR DIS, V121, P939
  • [9] POWERFUL BACTERICIDAL ACTIVITY OF SPARFLOXACIN (AT-4140) AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE
    LALANDE, V
    TRUFFOTPERNOT, C
    PACCALYMOULIN, A
    GROSSET, J
    JI, BH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) : 407 - 413
  • [10] THE ACTION OF ANTITUBERCULOSIS DRUGS IN SHORT-COURSE CHEMOTHERAPY
    MITCHISON, DA
    [J]. TUBERCLE, 1985, 66 (03): : 219 - 225